Embolization for adenomyosis symptoms
Part of Women’s health & pregnancy clinical trials.
This trial tests a non-surgical procedure called uterine artery embolization to treat adenomyosis symptoms like heavy bleeding and pelvic pain. If it works, it could be an alternative to removing the uterus.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman who has not gone through menopause yet.
- You have adenomyosis that causes symptoms like heavy or painful periods, either alone or along with fibroids.
- Your doctor has recommended a hysterectomy because other treatments have failed or you don't want them.
- You do not plan to get pregnant now or in the future.
- You have no pelvic infection, cancer, or other serious health issues that would make the procedure risky.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two treatments for heavy bleeding caused by adenomyosis: a procedure that uses heat to remove the inner lining of the uterus (endometrial ablation) and a procedure that blocks blood flow to the uterus (uterine artery embolization). If you have been diagnosed with adenomyosis and have tried medication without success, this trial may help decide which treatment is best for you.
This study compares two ways to treat adenomyosis to see which works better for symptom relief. You may be offered either microwave treatment or uterine artery embolization (a procedure that reduces blood flow to the affected area).
This trial tests a treatment called high-intensity focused ultrasound (HIFU) for adenomyosis, a condition where the lining of the uterus grows into the muscle wall, causing pain and heavy bleeding. The treatment uses sound waves to target and shrink the affected areas, which may help reduce symptoms.
This study follows people with adenomyosis to see which treatments work best for pain and heavy bleeding. It may help doctors find better ways to manage symptoms.
This early-stage study tests a new treatment for adenomyosis, a condition that can cause heavy bleeding and pelvic pain. The goal is to find a way to ease these symptoms, and it may be an option if you are between 30 and 50, have adenomyosis, and are not planning to become pregnant.
This study tests whether taking a medication called nintedanib before embryo transfer improves pregnancy chances in women with adenomyosis. Nintedanib may help by reducing inflammation and abnormal blood vessels in the uterus linked to adenomyosis.
Hear when a new Uterine Adenomyosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.